Riskpilot← Back to searchSign inGet full accessDE JOUNGE - EURENIUS AB
ABActiveOrg 5566112529Roslagsgatan 50 CWholesale of pharmaceutical and medical goods · NACE 4646Est. 20011-4 employees
Revenue 2025
SEK 797K
+5% vs 2024
EBITDA margin
-9.7%
-135% vs 2024
Equity ratio
76.8%
Financial strength
Net profit 2025
SEK -83K
-148% vs 2024
| Revenue | SEK 797K | +5% |
| EBITDA | SEK -78K | -135% |
| Net profit | SEK -83K | -148% |
| Total assets | SEK 444K | -18% |
| Equity | SEK 341K | -20% |
| Employees | — | — |
Legal name
DE JOUNGE - EURENIUS AB
Org number
5566112529
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31 maj 2001
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av De Jounge Eurenius, M Heléne Eurenius, Mats Åke
Company purpose
Bolaget skall bedriva tandläkeri, tandteknisk verksamhet, sjuk gymnastik, akupunkturkurser utbildning, hälsofrämjande verksamhet, fastighetsförvaltning, PR, testverksamhet samt därmed förenlig verksamhet samt import och försäljning av alkoholhaltiga drycker
Address
Roslagsgatan 50 C
Phone
+4687180035
Email
info@dejeab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 088 | 639 | 620 | 757 | 797 |
| Staff expenses | — | −426 | −148 | −136 | −128 |
| EBITDA | 158 | −17 | 150 | 220 | −78 |
| Depreciation & amort. | −5 | −5 | −5 | −5 | −5 |
| EBIT | 153 | −22 | 145 | 215 | −83 |
| Net financials | — | −3 | 0 | 1 | 0 |
| Profit before tax | 153 | −25 | 145 | 215 | −83 |
| Tax | −33 | — | −25 | −44 | — |
| Net profit | 120 | −25 | 120 | 171 | −83 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 550 | 398 | 581 | 539 | 444 |
| Equity | 297 | 273 | 333 | 424 | 341 |
| Long-term debt | 115 | 61 | 99 | 67 | 88 |
| Short-term debt | 138 | 65 | 149 | 48 | 15 |
| Total debt | 253 | 126 | 248 | 115 | 103 |
EBITDA margin
-9.7%
This company
15.8%
Market median
-161% vs market
20212025
Equity ratio
76.8%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
-24.3%
This company
18.4%
Market median
-232% vs market
20212025
Net profit margin
-10.4%
This company
8.1%
Market median
-228% vs market
20212025
Asset turnover
1.80×
This company
1.12×
Market median
+61% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DE JOUNGE - EURENIUS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| M Heléne De Jounge Eurenius | Board of Directors | 0 companies |
| Mats Åke Eurenius | Deputy Board Member | 0 companies |